Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast

@article{Zhang2003QuantitativeDB,
  title={Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast},
  author={Zhenhuan Zhang and Hiroko Yamashita and Tatsuya Toyama and Yoko Omoto and Hiroshi Sugiura and Yasuo Hara and Xueqing Wu and Shunzo Kobayashi and Hirotaka Iwase},
  journal={Breast Cancer Research},
  year={2003},
  volume={5},
  pages={R250 - R256}
}
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor (ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase. Previous studies comparing the relative contributions from tumor cells and stromal cells to local estrogen synthesis, as assessed by immunohistochemical analysis, were quite controversial and no consistent relationship was found between the presence of aromatase and any… CONTINUE READING

3 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
EstrogensContraindicated with diseaseMammary Neoplasms
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor ( ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by aromatase .
All Topics